Bhattacharya, Dipabarna http://orcid.org/0000-0002-0808-7783
Theodoropoulos, Jason
Nurmi, Katariina
Juutilainen, Timo
Eklund, Kari K.
Koivuniemi, Riitta
Kelkka, Tiina
Mustjoki, Satu
Lönnberg, Tapio http://orcid.org/0000-0003-4484-5657
Funding for this research was provided by:
European Research Council (M-IMM 647355)
Academy of Finland Heal-Art consortium (314442)
Sigrid Juséliuksen Säätiö
Signe ja Ane Gyllenbergin Säätiö
Helsinki Institute of Life Science, Helsingin Yliopisto
Syöpäsäätiö
Academy of Finland (311081)
InFLAMES Flagship Programme of the Academy of Finland (337530)
Finnish Blood Disease Research Foundation
University of Helsinki
Article History
Received: 11 April 2023
Accepted: 21 February 2024
First Online: 9 April 2024
Declarations
:
: Written informed consent was received from all patients. This study was approved by the Helsinki University Hospital Ethics Committee (HUS/2989/2017).
: We have obtained consent to publish this paper from all the participants of this research.
: SM has received honoraria and research funding from Novartis, Bristol-Myers Squibb, Incyte, and Pfizer (not related to this project). Other authors have no competing interest to declare.